XRHealth R&D Ltd.

www.xr.health

Formerly VRPhysio, VRHealth

High-Tech Company

TECH VERTICALS

AgeTech, Artificial Intelligence, Augmented Reality, B2C, Chronic Pain, Data Analytics, Digital Health, Extended Reality, Healthtech, Impact, Life Sciences, Managed Care, MedTech, Mental Health, Metaverse, Psychology, Rehabilitation, Sensors, Telehealth, Therapy, Virtual Reality, Wellness

General Data

Sector	Digital Health
Company Stage:	Revenue Growth
Established	2016
Number of Employees	119
Employees in Israel	20
Reg. Number:	abCDe

DESCRIPTION

XRHealth is a digital health technology company that develops extended reality (XR)–based therapeutic solutions incorporating virtual reality (VR) and augmented reality (AR) into clinical workflows. The company functions as both a technology platform and a provider of virtual healthcare services. Its applications are used for physical rehabilitation, pain management, cognitive training, and mental health treatment. The solutions are FDA-registered and are intended for use by clinicians, healthcare organizations, and patients in both remote and in-clinic settings.

TECHNOLOGY

Extended Reality (XR); Virtual Reality (VR) for various therapy areas such as pain management, cognitive training, mindfulness, and physical rehab; Augmented Reality (AR) applications; Immersive therapeutic environments; Advanced data analytics, Remote patient monitoring; Telehealth platform infrastructur.

Products and Phases

Product	Phase
VRPhysio Home™ MT-220 (Balloon Blast)	FDA Approved
Software-only medical device intended for upper extremity and full body rehabilitation. The software tracks motion and movement kinematics and guides patients in the performance of physical exercises according to their treating medical practitioner's guidelines.
VRPhysio Home™ MC-320 (Color Match)	FDA Approved
Software-only medical device intended for motor-cognitive rehabilitation. The software tracks motion and movement kinematics and guides patients in the performance of motor-cognitive exercises according to their treating medical practitioner's guidelines.
VRReliever™ CB-510 (Luna)	FDA Approved
Intended to assist in the mitigation of pain, hot flashes and physical discomfort through distraction and supporting exercises, performed in a virtual reality (VR) environment using commercially available VR headsets.
VRPhysio Home™ N-140 (Rotate)	FDA Approved
Neck exercises application providing measurements and metrics including range of motion, smoothness of the motion and improvement over time.
VRReliever™ MD-710 (Relax8)	FDA Approved
Intended to assist in relaxation and management of pain and physical discomfort through distraction and supporting meditation and relaxation exercises, performed in a virtual reality (VR) environment using commercially available VR headsets.
VRReliever™ PD-810 (Mindset)	FDA Approved
Healing media center app, based on a variety of proven wellness and cognitive therapy methods. The app promotes meditation and relaxation.
VRBehavior™ VRET-910 (Expose)	FDA Approved
Intended as a tool used by a Licensed Healthcare Providers (LHP) to immerse their patients in simulated virtual reality (VR) environments in remote or in-person sessions in order to improve certain mental health conditions, using commercially available VR headsets.
VRCBT™ AT-910 (A10tion)	FDA Approved
A virtual reality immersive therapeutic application designed to train and improve cognitive function in patients diagnosed with ADHD. The application is a clinician-monitored program intended for use as part of a comprehensive therapeutic plan that includes clinician-directed therapy.
VRCogni™ CT-610 (Re-Act)	FDA Approved
A software-only medical device designed to support the assessment and mitigation of cognitive function–related conditions through cognitive exercises and performance measurements. It uses visual and auditory stimuli and hand-based interactions to guide tasks, track movement kinematics, and monitor performance over time.
VRCogni™ CT-620 (Memorize)	FDA Approved
A prescription only medical device software applications that provide various VR environments to aid mitigate or assess conditions related to cognitive function by providing cognitive exercises and cognitive ability measurements.

	TARGET MARKETS
	Healthcare providers, Hospitals, Rehabilitation centers, Patients (direct to consumer).

	BUSINESS MODEL
	B2B

COMPETITORS

Sixense

REMARKS

Date	Remark
10/01/2024	The XRHealth VR/AR telehealth platform is ISO certified, FDA certified and HIPAA compliant.

CONTACT INFO

Expand / Collapse All

Main Address: Needham, United States

Address	200 Highland Ave., STE 202
City	Needham
State/Province	MA
Country	United States
Zip	02494

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Tel Aviv, Israel

Address	32 Shocken St., Floor 2 (at 2b angels)
City	Tel Aviv
Country	Israel
Zip	6655613

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Melbourne, Victoria, Australia

City	Melbourne, Victoria
Country	Australia

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Barcelona, Spain

City	Barcelona
Country	Spain
Zip	08001

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Eran Orr	CEO & Co-Founder
Mr. Miki Levi	CTO & Co-Founder, GM Israel
Mr. Xavier Oromi	Head of R&D
Ms. Maya Bein-Nachal	CMO
Ms. Maria Fierro Massana	CFO
Mr. Francisco Palomares-Barrios	VP, Engineering

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Managing Partner, 20/20 HealthCare Partners
abC Defghij	Board Member	Co-Founder, Neura
abC Defghij	Board Member	CEO & Co-Founder, XRHealth
abC Defghij	Board Member	CTO & Co-Founder, XRHealth
abC Defghij	Board Member	Managing Partner, Bridges Israel Fund
abC Defghij	Board Member	Managing Partner, AI Capital
abC Defghij	Observer	Principal, Flint Capital

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Fourth Round

Jan. 09, 2024

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Bank	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Professional Services Company	abCDe
abC Defghij	High-Tech Company	abCDe

Third Round

Feb. 28, 2022

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe	Equity crowdfunding platform.
abC Defghij	Bank	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Professional Services Company	abCDe
abC Defghij	High-Tech Company	abCDe	Via HTC VIVE

Second Round

Jun. 03, 2021

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Bank	abCDe	Led the round
abC Defghij	Investment Company	abCDe

First Round - Extended

Apr. 22, 2020

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe	Led the round
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

First Round

Dec. 12, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Angel Syndicate	abCDe	Private Investors via ExitValley Equity Crowdfunding Platform.

Seed - Extended

Aug. 06, 2017

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Corporate VC	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Seed

Jul. 01, 2016

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

May. 01, 2024

Revenue Growth

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Mar. 01, 2022

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jul. 13, 2020

Initial Revenues

abCDe

Co-op with Beth Israel Deaconess Medical Center (Boston, MA).

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-National Fund	abCDe

R&D Grant

Jun. 01, 2020

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

May. 06, 2020

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Dec. 14, 2017

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Dec. 11, 2016

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Jun. 29, 2021

Initial Revenues

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

Non-Equity Assistance

Jun. 01, 2017

R&D

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

	Acquisitions made by XRHealth

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	Digita...	Dec. 02, 2025	abCDe
abC Defghij	Digita...	Feb. 18, 2025	abCDe
abC Defghij	Digita...	Nov. 06, 2024	abCDe
abC Defghij	Digita...	Apr. 18, 2023	abCDe

Last Updated:	abCDe
IVC Number:	abCDe